Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




AI-Based Platform Designed to Classify Strokes Quickly

By HospiMedica International staff writers
Posted on 24 Apr 2018
An artificial intelligence (AI)-based stroke diagnosis platform designed to assist doctors in quickly classifying the cause of a stroke has completed clinical trials and is expected to provide key information to determine treatment for stroke, leading to faster and more-precise decision-making for patients.

The platform has been developed by JLK Inspection (Seoul, South Korea), a deep learning and AI company. More...
The company specializes in combining AI and image-processing technologies with medical expertise. JLK utilizes AI and deep learning technologies to analyze MRI images of stroke patients to help classify the cause of a stroke. In order to train the AI platform, JLK has secured billions of pieces of data from millions of cases through collaborations with hospitals in Korea. Researchers at JLK are working with these institutions to help train the software to analyze the provided data correctly. The company expects the AI-based stroke diagnosis platform to work as a virtual "skilled assistant" to help physicians assess medical images as accurately as possible.

"It is inspiring in that, JLK Inspection has a platform for CT-based hemorrhagic stroke detection as well as for MRI-based ischemic stroke diagnosis at a time when its peers are only working in the hemorrhagic stroke detection area," said Wontae Kim, CEO of JLK Inspection. "Fast diagnosis using our solution is essential in treating strokes, helping provide more time for faster treatment, while potentially saving lives and millions in medical expenses."

Additionally, JLK Inspection is also building an AI-based general and universal medical platform to cover various other diseases and conditions such as dementia and prostate cancer, among others, by working closely with globally renowned hospitals and research centers.

Related Links:
JLK Inspection


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Endoscopy Display
E190
Neonatal Ventilator Simulation Device
Disposable Infant Test Lung
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: A smartphone application displays a glucose concentration that was measured using the new sensor (Photo courtesy of Chuchu Chen and Yonghao Fu)

Wearable Device for Diabetics Could Replace Continuous Glucose Monitoring Systems

Monitoring blood glucose is essential for people with diabetes to prevent complications and maintain long-term health. Current continuous glucose monitoring systems require needles inserted under the skin,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.